Press release
Pharmacogenomics (PGx) Market Skyrocketing Revenue Growth of USD 11.63 Billion, +7% CAGR by 2030
Pharmacogenomics (PGx) Market
Pharmacogenomics (PGx), is the study of how people respond differently to drug therapy based upon their genetic makeup. Pharmacogenomics is part of the field of precision medicine, which aims to treat each patient individually. It uses genomic information to study individual responses to drugs and helps healthcare provider to choose the right drug for each individual patient. Tailoring a patient's medication to their unique genetic characteristics can replace the one-size-fits-all approach to dosing and drug selection that is commonly used today.
The report comes out as an intelligent and thorough assessment tool and a great resource that will help you secure a position of strength in the global Pharmacogenomics (PGx) market. It includes Porter's Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Pharmacogenomics (PGx) Market. We have provided deep analysis of the vendor landscape to give you a complete picture of current and future competitive scenarios of the global Pharmacogenomics (PGx) market. Our analysts use the latest primary and secondary research techniques and tools to prepare comprehensive and accurate market research reports.
Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart): https://globalmarketvision.com/sample_request/182448
This report examines all the key factors influencing the growth of the Pharmacogenomics (PGx) market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis. Regional assessment of Pharmacogenomics (PGx) market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, the scope in new markets, pricing strategies, innovation possibilities, and much more.
Key Players Influencing the Pharmacogenomics (PGx) Market:
• Abbott Laboratories
• Affymetrix, Inc.
• Assurex Health, Inc
• Astrazeneca
• GeneDX
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Myriad Genetics, Inc.
• Pathway Genomics
• Pfizer, Inc
• Qiagen, Inc.
• Rocheg
• Teva Pharmaceutical Industries Ltd.
• Thermo Fisher Scientific
• Transgenomic, Inc.
This study looks at the main market in Pharmacogenomics (PGx) strategies, such as product releases, partnerships, mergers and acquisitions, and so on. The value of strategic research has been thoroughly analysed in light of undeniable market dynamics.
Market Segmentation:
Based on the type, the market is segmented into
• Polymerase Chain Reaction (PCR)
• Microarray
• Sequencing
• Other
Based on the application, the market is segregated into
• Cardiovascular Diseases (CVD)
• Central Nervous System (CNS)
• Cancer/Oncology
• Infectious Diseases
• Other
The Pharmacogenomics (PGx) market is divided into various essential sectors, including application, type, and region. Each market segment is intensively studied in the report, considering market acceptance, value, demand, and growth prospects. Segmentation analysis allows customers to customize their marketing approach to perform better orders for each segment and identify the most prospective customer base.
In terms of geography, this research report covers almost all major regions of the world, such as North America, Europe, South America, the Middle East, and Africa, and Asia Pacific. Europe and North America are expected to increase over the next few years. The Pharmacogenomics (PGx) market in the Asia Pacific is expected to grow significantly during the forecast period. The latest technologies and innovations are the most important characteristics of North America and the main reason the United States dominates the world market. The South American Pharmacogenomics (PGx) market is also expected to grow in the near future.
Central issues referenced in the report incorporate
• The information contains insights concerning the significant players that assume a significant part in the business space.
• It gives thorough evaluation of the entire business space.
• It offers bits of knowledge about the key chances and development prospects that are adding to the market development.
• It offers insights about the significant methodologies and business strategies followed by the business experts in the course of recent years.
• The record reveals insight into the figures relating to the production and utilization volume and worth.
• The record assesses the store network environment and gives a thought regarding the whole interest and supply.
• It assesses the recorded occasions and predicts the future occasions in the estimate time period.
Table of Content (TOC):
Chapter 1 Introduction and Overview
Chapter 2 Industry Cost Structure and Economic Impact
Chapter 3 Rising Trends and New Technologies with Major key players
Chapter 4 Global Pharmacogenomics (PGx) Market Analysis, Trends, Growth Factor
Chapter 5 Pharmacogenomics (PGx) Market Application and Business with Potential Analysis
Chapter 6 Global Pharmacogenomics (PGx) Market Segment, Type, Application
Chapter 7 Global Pharmacogenomics (PGx) Market Analysis (by Application, Type, End User)
Chapter 8 Major Key Vendors Analysis of Pharmacogenomics (PGx) Market
Chapter 9 Development Trend of Analysis
Chapter 10 Conclusion
Purchase This Report@ https://globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=182448
Additionally, in case you are interested in other topic at the moment, please share your exact requirements with us as apart from our off-the-shelf reports, we also provide customized reports that are prepared keeping in view the clients precise requirements. To let you know, on an annual basis, we publish over 450+ report across 18 distinct industry verticals.
Contact Us
Sarah Ivans | Business Development
Phone: +1 617 297 8902
Email: sales@globalmarketvision.com
Global Market Vision
Website: www.globalmarketvision.com
About Global Market Vision
Global Market Vision a legacy of exceptional knowledge, integrated into providing service offers a one-stop solution that surpasses core research processes & industry standards focusing on the client's competency, strategies, growth factors, and business intelligence by creating an algorithm for meaningful data insights and presentations through a unique blend of vast industry coverage, expertise in every domain, professional work ethics & values, data authenticity & privacy.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics (PGx) Market Skyrocketing Revenue Growth of USD 11.63 Billion, +7% CAGR by 2030 here
News-ID: 3050617 • Views: …
More Releases from Global Market Vision
Rapid Growth in Solar Pump Market Driven by Clean Energy Demand and Government I …
[Pune, India] - [10/07/2025] - [Global Market Vision], a leading provider of market intelligence, has released its latest report on the Solar Pump Market, projecting significant growth driven by rising demand for renewable energy solutions, increasing agricultural modernization, and supportive government policies worldwide.
According to the GMV, the global solar pump market is expected to grow at a CAGR of 33%, reaching INR 60 billion by 2024. This growth is fueled…
5G in Healthcare: The Next Frontier for Innovation and Patient Care
Market Overview:
The fundamental components of healthcare could all be changed and enhanced by 5G networks. Over the past several years, the use of 5G networks in healthcare has increased, and their applications have been strengthened by advancements in robotics, IoT, and AI that will change healthcare systems into a new connected ecosystem. The main challenge faced by healthcare systems is the fastest transmission of data.
5G technology is revolutionizing the healthcare…
Dual Screen Laptops Market Size, Share, Trends, Growth Report and Forecast
The global dual-screen laptops market is witnessing steady growth, with a forecasted increase from $2.59 billion in 2023 to $3.26 billion by 2028, driven by a compound annual growth rate (CAGR) of about 5.0%. This growth is fueled by advancements in display technology, the rising demand for portable devices, and the growing popularity of dual-screen laptops among gamers, content creators, and professionals who benefit from the enhanced multitasking capabilities these…
Active & Intelligent Packaging Market Market Data and In-depth Analysis to 2032 …
Future Market Consulting Global Market Vision has published a research report on the "Global Active & Intelligent Packaging Market", which provides a comprehensive outline of the factors responsible for the market growth from 2018 to 2032. The Active & Intelligent Packaging Market value is USD XX million in 2023 and is expected to grow to USD XX million by 2032 with a CAGR of XX% during the forecast period. …
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
